The Human Variable 

CRISPR²™ (CRISPR Readiness Index, Stabilization, Personalized Recovery) introduces a state-dependent framework for gene editing in complex chronic disease. Unlike conventional models that assume biological stability, CRISPR² integrates patient readiness, environmental exposure, temporal symptom dynamics, and recovery conditions to guide when and how intervention occurs. This approach expands therapeutic reach across severity levels, improves interpretation of outcomes in vari

Remission is often defined as symptom improvement at a single moment in time. The CYNAERA Remission Standard™ challenges that assumption by introducing a state-dependent model that evaluates stability, durability, function, flare control, and resilience over time. Applied across Long COVID, autoimmune disease, and clinical trials, this framework provides a more accurate way to measure recovery, reduce misclassification, and align outcomes with real-world patient experience.

Personalized CRISPR Remission™ for Long COVID introduces a state-dependent gene editing framework based on biological readiness, stabilization, and recovery to improve timing, safety, and durability in immune-volatile disease.

A field guide for designing Lyme disease clinical trials that work. Learn how to improve outcomes using adaptive design, co-infection stratification, digital biomarkers, and CYNAERA’s stabilization-first framework.

A new framework for disease prevalence estimation, the Diagnostic Multiplier™ (DM™) adjusts for underdiagnosis, diagnostic variability, and environmental exposure across conditions.

Pediatric Long COVID in the U.S. may affect 6–10 Remission in Long COVID is often described as partial, inconsistent, or spontaneous. That framing is misleading. What appears random is often the result of poor temporal measurement. Long COVID is not a static illness state. It is a fluctuating systems condition in which symptom burden, immune signaling, autonomic regulation, vascular tone, and exertional tprevalence, symptoms, underdiagnosis, and public health implications usi